BP@CeO x showed the same three characteristic Raman peaks of BP nanosheets, which were ascribed to one out-of-plane phonon mode ( A 1 g ) at 363 cm -1 , and two in-plane modes ( B 2g and A 2 g ) at 439 and 467 cm -1 , respectively, suggesting that the combination of CeO x did not cause the structural transformation of pure BP
Rosacea is not solely a gut condition, but poor digestion and imbalances like leaky gut or SIBO can be a contributing factor
NAD+ vs NMN vs NR (and IV vs SubQ) NAD+ Delivery Comparison Feature Mechanism NAD+ Injection (SubQ) Direct coenzyme delivery NAD+ Infusion (IV) Direct coenzyme delivery Oral NMN NAD+ precursor (converted in vivo) Oral NR (Niagen) NAD+ precursor (converted in vivo) Feature Typical research-planning dose NAD+ Injection (SubQ) 50-100 mg, 2-3x/week NAD+ Infusion (IV) 250-1,000 mg per session Oral NMN 300-600 mg/day Oral NR (Niagen) 300-1,000 mg/day Feature Speed to systemic NAD+ rise NAD+ Injection (SubQ) Hours NAD+ Infusion (IV) Minutes to hours Oral NMN Days to weeks Oral NR (Niagen) Days to weeks Feature Strongest human evidence NAD+ Injection (SubQ) Limited NAD+ Infusion (IV) Pilot PK and historical case reports Oral NMN Growing RCT base Oral NR (Niagen) Strongest RCT base Feature Convenience NAD+ Injection (SubQ) At-home injection technique required NAD+ Infusion (IV) Clinic visit, 2-4 hour infusion Oral NMN Daily oral capsule Oral NR (Niagen) Daily oral capsule Feature Regulatory status NAD+ Injection (SubQ) Not FDA-approved
They increase the levels of dopamine and norepinephrine, which are neurotransmitters (brain chemicals) involved in reward and motivation
